In-Vivo Polarized Nuclear Imaging

体内偏振核成像

• 批准号: 9435295
• 负责人: GORDON D CATES
• 金额: $ 23.82万
• 依托单位: UNIVERSITY OF VIRGINIA
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-01-01 至 2019-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9435295
• 关键词: Address; Animals; Bolus Infusion; Cell Nucleus; Cells; Data; Detection; Development; Diagnostic; Dimensions; Electromagnetic Energy; Electromagnetics; Gamma Cameras; Gamma Rays; Gases; Glass; Goals; Image; Imaging Phantoms; Imaging technology; In Vitro; Inhalation; Isotopes; Journals; Lasers; Lung; Magnetic Resonance; Magnetic Resonance Imaging; Medical; Medical Imaging; Modality; Modeling; Nature; Nuclear; Optics; Oryctolagus cuniculus; Physiologic pulse; Process; Publishing; Pump; Radioactive Tracers; Research; Resolution; Scheme; Signal Transduction; Site; Source; System; Techniques; Time; Tracer; Water; base; data acquisition; detector; image reconstruction; imaging modality; improved; in vivo; in vivo imaging; interest; magnetic field; novel; novel strategies; nuclear imaging; programs; radio frequency; spectroscopic imaging; statistics; tumor; two-dimensional

ABSTRACT Magnetic resonance imaging (MRI) provides exquisite spatial resolution, spectral sensitivity, and a rich variety of contrast mechanisms for diagnostic medical applications. Nuclear imaging using gamma cameras offers the benefits of using small quantities of radioactive tracers that seek specific targets of interest within the body. We have developed a new imaging and spectroscopic modality, recently published in the journal Nature, which utilizes favorable aspects of both approaches. Spatial information is encoded into the spin orientations of tiny amounts of a polarized radioactive tracer using pulses of both radio-frequency electromagnetic radiation (RF) and magnetic-field gradients, as in MRI. Rather than detecting the inherently weak electromagnetic signals from the precessing magnetization, however, imaging information is obtained through the detection of gamma rays emitted from the polarized nuclei. Unlike nuclear imaging, even a single gamma-ray detector can be used to acquire an image; no gamma camera is needed. Our new modality takes advantage of the fact that polarized nuclei with spin > ½ emit gamma rays in a spatially anisotropic fashion with respect to the direction along which they are oriented. We refer to our new technique as Polarized Nuclear Imaging (PNI). Despite our successful proof-of-concept demonstration, significant challenges remain in moving to in vivo applications. The long-term goal of our research is to establish PNI as a practical medical imaging technology that addresses unmet medical diagnostic needs. Our short-term goal addressed in this application is to demonstrate the feasibility of in vivo use, by producing the first polarized nuclear images in a living animal. Our specific aims are: (1) to develop a pulse sequence strategy for PNI that is suitable for in-vivo application, and to demonstrate its efficacy by acquiring two-dimensional images in glass-cell phantoms; and (2) to demonstrate polarized nuclear imaging for the first time in a living animal, by acquiring one-dimensional images of inhaled 131mXe in rabbit lungs. Successful completion of these aims will lay the basis for PNI to become a practical new imaging modality, and will demonstrate the potential of PNI to create a new class of medical tracers.

摘要 磁共振成像（MRI）提供了精致的空间分辨率，光谱灵敏度和丰富的种类 用于诊断医学应用的对比机制。使用伽马照相机的核成像提供了 使用少量放射性示踪剂的好处是在体内寻找感兴趣的特定目标。我们 他们开发了一种新的成像和光谱模式，最近发表在《自然》杂志上， 利用两种方法的有利方面。空间信息被编码成微小的 使用射频电磁辐射（RF）和电磁辐射（RF）的脉冲， 和磁场梯度，就像核磁共振一样而不是检测固有的微弱电磁信号 然而，根据旋进磁化，成像信息是通过伽马的检测获得的。 从极化的原子核发出的射线。与核成像不同的是，即使是单个伽马射线探测器也可以使用 以获取图像;不需要伽马照相机。我们的新模式利用了这样一个事实， 自旋> 1/2的极化核以相对于方向的空间各向异性方式发射伽马射线 沿着它们被定向。我们将我们的新技术称为极化核成像（PNI）。尽管我们 尽管成功的概念验证演示，但在转向体内应用方面仍然存在重大挑战。的 我们研究的长期目标是将PNI建立为一种实用的医学成像技术， 未满足的医疗诊断需求。我们在此应用程序中解决的短期目标是演示 通过在活体动物中产生第一个极化核图像，证明了体内使用的可行性。我们的具体目标 （1）开发适用于体内应用的PNI的脉冲序列策略，并证明 通过在玻璃细胞模型中获取二维图像来验证其功效;以及（2）证明偏振 首次在活体动物中进行核成像，通过获取吸入的131毫微克的一维图像， 兔子肺这些目标的顺利实现将为PNI成为一种实用的新型成像技术奠定基础 模式，并将展示PNI的潜力，创造一个新的一类医疗示踪剂。